Piperidine glycine transporter inhibitors

Details for Australian Patent Application No. 2006309050 (hide)

Owner Merck Sharp & Dohme Limited Merck Sharp & Dohme Corp.

Inventors Zhao, Zhijian; Nolt, Brad M.; Hallett, David; Wolkenberg, Scott E.; Theberge, Cory R.; Lindsley, Craig W.; Naylor, Elizabeth M.

Agent Spruson & Ferguson

Pub. Number AU-B-2006309050

PCT Pub. Number WO2007/053400

Priority 60/731,010 28.10.05 US

Filing date 27 October 2006

Wipo publication date 10 May 2007

Acceptance publication date 16 August 2012

International Classifications

A61K 31/445 - Non-condensed piperidines, e.g. piperocaine

A61P 25/00 Drugs for disorders of the nervous system

A61P 25/18 Drugs for disorders of the nervous system

Event Publications

1 May 2008 PCT application entered the National Phase

  PCT publication WO2007/053400 Priority application(s): WO2007/053400

13 May 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Limited; Merck Sharp & Dohme Corp.

16 August 2012 Application Accepted

  Published as AU-B-2006309050

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Limited; Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006309059-Radiation diffraction colorants

2006309044-Kinase inhibitors